Aziende Chimiche Riunite Angelini FRANCESCO—A.C.R.A.F. S.p.A.
USPTO PatentsView assignee record - 28 granted patents across 9 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Aziende ranks #10,865 of 49,997 tracked US assignees by granted-patent volume, with 28 patents across 9 technology areas.
- #10,865
- of 49,997 US assignees by volume
- 44th percentile
- by Innovation Score (33.4/100)
- 14.5
- avg claims per patent
- -63%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R10865 · Foreign Corporation #10,865 · 28 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
- GRANTS-SMALL 28 grants
- UPPER-Q #10,865/49,997
- PHOTO-FINISH Acbel Polytech
- CPC-NARROW A61P · 9 areas
- INNOV-THIN 33.4/100
- CLAIMS-RICH 14.5 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DROP -63% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Acbel Polytech Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Aziende’s 33.4 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Aziende
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- LSI Medience · near 33
LSI Medience · near
33 score
- Tokuden · near 33
Tokuden · near
33 score
- Uniloc Luxembourg · near 33
Uniloc Luxembourg · near
33 score
- Automotive Energy… · near 33
Automotive Energy… · near
33 score
- Aziende Chimiche… · this assignee 33
Aziende Chimiche… · this assignee
33 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Aziende's Innovation Score is 33.4/100 (44th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Aziende?
Each dot is one of Aziende’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Aziende’s own 14.5 claims/patent is at or below the 15.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Aziende's grants concentrate
Aziende Chimiche Riunite Angelini FRANCESCO—A.C.R.A.F. S.p.A. is a focused PatentsView assignee: 9 CPC subclasses with 78.6% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2016 (4 grants) versus a trough of 1 in 2022. By volume, Aziende sits between Applejack 199 L.P. and Alltec Angewandte Laserlicht Technologie GmbH.
Aziende's three-year grant acceleration
Aziende Chimiche Riunite Angelini FRANCESCO—A.C.R.A.F. S.p.A. shows 3 grants in 2022–2024 against only 8 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Aziende's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Applejack 199
Applejack 199 L.P.
28 patents
- Arizona Board OF…
Arizona Board OF Regents, Acting FOR AND ON Behalf OF Arizona State University
28 patents
- Asian Power Devic…
Asian Power Devices Inc.
28 patents
- Astenjohnson
Astenjohnson, Inc.
28 patents
- Acbel Polytech
Acbel Polytech Inc.
28 patents
- Action Target
Action Target Inc.
28 patents
- Alkermes
Alkermes, Inc.
28 patents
- Alltec Angewandte…
Alltec Angewandte Laserlicht Technologie GmbH
28 patents
- Aziende Chimiche… ◀
Aziende Chimiche Riunite Angelini FRANCESCO—A.C.R.A.F. S.p.A.
28 patents
What this shows Aziende holds 28 patents at rank #10,848, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Aziende
By rank, the assignees closest to #10,848 in granted patent volume.
- Applejack 199 L.P. #10,844 · 28 patents
- Arizona Board OF Regents, Acting FOR AND ON Behalf OF Arizona State University #10,845 · 28 patents
- Asian Power Devices Inc. #10,846 · 28 patents
- Astenjohnson, Inc. #10,847 · 28 patents
- Acbel Polytech Inc. #10,849 · 28 patents
- Action Target Inc. #10,850 · 28 patents
- Alkermes, Inc. #10,851 · 28 patents
- Alltec Angewandte Laserlicht Technologie GmbH #10,852 · 28 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Aziende's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Aziende, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Aziende ranks #884 of 6,058 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (33 here).
Aziende's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
33 44th percentile higher than 44% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 3 | 10.7% |
| 2016 | 4 | 14.3% |
| 2017 | 4 | 14.3% |
| 2018 | 4 | 14.3% |
| 2019 | 4 | 14.3% |
| 2020 | 4 | 14.3% |
| 2022 | 1 | 3.6% |
| 2023 | 1 | 3.6% |
| 2024 | 1 | 3.6% |
| 2025partial year | 2 | 7.1% |
Which technologies does Aziende Chimiche Riunite Angelini FRANCESCO—A.C.R.A.F. S.p.A. patent most?
Top 9 of 9 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Aziende Chimiche Riunite Angelini FRANCESCO—A.C.R.A.F. S.p.A.'s patent record in context - here's where to go next.
- Aziende Chimiche Riunite Angelini FRANCESCO—A.C.R.A.F. S.p.A.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 78.6% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #10,865 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Aziende Chimiche Riunite Angelini FRANCESCO—A.C.R.A.F. S.p.A. against Applejack 199 L.P., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 33.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.